GlaxoSmithKline Pharmaceuticals Technical Analysis
- Market cap
- ₹44,821 crore
- P/E
- 42.0
- P/B
- 19.77
- ROE
- 49.1%
- Dividend yield
- 1.20%
As of 7 October 2026, GlaxoSmithKline Pharmaceuticals (GLAXO) closed at . The 14-day RSI is 58.50, between the oversold (30) and overbought (70) levels.
GlaxoSmithKline Pharmaceuticals moving averages
Last close on 7 Oct 2026. "Price vs" shows whether the close is above or below each average.
| Period | SMA | Price vs SMA | EMA | Price vs EMA |
|---|---|---|---|---|
| 5-day | 2,619.34 | — | 2,619.34 | — |
| 10-day | 2,592.88 | — | 2,592.88 | — |
| 20-day | 2,566.43 | — | 2,566.43 | — |
| 50-day | 2,513.51 | — | 2,513.51 | — |
| 100-day | 2,434.14 | — | 2,434.14 | — |
| 200-day | 2,328.30 | — | 2,328.30 | — |
GlaxoSmithKline Pharmaceuticals momentum indicators
| RSI (14) | 58.50 |
|---|---|
| MACD (12, 26) | 12.40 |
| MACD signal (9) | 10.20 |
| MACD histogram | — |
| ADX (14) | 24.20 |
| Stochastic %K / %D (14, 3) | 65.00 / 60.00 |
GlaxoSmithKline Pharmaceuticals trend
Close compared with its 20-day (short), 50-day (medium) and 200-day (long) simple moving averages.
- Short term (20-day)
- —
- Medium term (50-day)
- —
- Long term (200-day)
- —
Source: Calculated by ATS from NSE end-of-day closing prices (adjusted for splits and bonus issues), last 365 days. Data as of 7 October 2026. How this data is compiled.
GlaxoSmithKline Pharmaceuticals technical analysis — frequently asked questions
What is the 200-day moving average of GlaxoSmithKline Pharmaceuticals?
GlaxoSmithKline Pharmaceuticals' 200-day simple moving average was ₹2,328.30 on 7 October 2026, and its 200-day exponential moving average ₹2,328.30. The last close of is below the 200-day SMA.
Is GlaxoSmithKline Pharmaceuticals above its 50-day moving average?
No — on 7 October 2026 GlaxoSmithKline Pharmaceuticals closed at , against a 50-day simple moving average of ₹2,513.51.
What is the RSI of GlaxoSmithKline Pharmaceuticals?
The 14-day Relative Strength Index for GlaxoSmithKline Pharmaceuticals was 58.50 on 7 October 2026, between the oversold (30) and overbought (70) levels. RSI measures the speed of recent price changes on a 0–100 scale.
What is the MACD of GlaxoSmithKline Pharmaceuticals?
On 7 October 2026 the MACD (12, 26, 9) line for GlaxoSmithKline Pharmaceuticals was 12.40 and the signal line 10.20, so the MACD was above its signal line.
How are these GlaxoSmithKline Pharmaceuticals technical indicators calculated?
ATS calculates them from the NSE's daily closing prices for the last 365 days, adjusted for splits and bonus issues: simple and exponential moving averages over 5 to 200 sessions, a 14-day RSI with Wilder smoothing, MACD (12, 26, 9) and a 14-day ADX. They describe past prices and are not a forecast or a recommendation.
Same Data For Peers
Trade GlaxoSmithKline Pharmaceuticals With ATS
Track GLAXO live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.